• Telephone : (855) 802-0299
  • Email Address: IR@GreenHygienics.com
  • Head Office: | POWAY, CA | 92064

Posts classified under: Image

SAN DIEGO, July 1, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") invites investors to attend its virtual shareholders update meeting on July 12 at 1:15 p.m. Pacific Standard Time. Ron Loudoun, CEO of Green Hygienics, will host the call and provide an overview of recent announcements, continued improvements to the Company's balance sheet, an overview of the revenue-focused build out of sales and distribution, and the 2021 fiscal strategy for the Company.

The Company’s corporate mission remains to adhere to the highest standards of operations in consistently delivering safe and premium quality products to our primary target market, the medical, nutraceutical and pharmaceutical industries. The Company also looks to leverage these same strategic advantages in partnerships with CPG (consumer-packaged-goods) companies.

“To that end significant progress has been made on both fronts and we welcome the opportunity to provide further detail to our investors regarding the material nature of these developments. It's important to share this information with investors, so they understand how to properly value our company," states Loudoun.

Year to Date Achievements and Recent Operational Highlights

  • Closed the acquisition of Primordia assets at a discount and expanded the Company’s cultivation capacity considerably.

  • Closed the acquisition of Castillo Seed Company assets at a discount and fast tracked the Company’s genetics division.

  • Closed the acquisition of American Hemp and Diablo CBD Smoke brands that included inventory valued at $22 million MSRP to add tremendous value to the balance sheet and launch a smokables division.

  • Signed an LOI to acquire Bohemian Beverage Co. and to mitigate risk in the Company’s entry into the CBD Beverage market.

  • Added key personnel to roll out plans for an in-house processing division and secured a Contract of Purchase and Sale to acquire a 37,000-square-foot light industrial building located just outside of San Diego and 55 minutes from the Sol Valley Ranch. It will serve as a new head office and support the Company’s plan to build out the largest first-in-class post processing facility in the U.S.

  • Launched TruLife Biotech, LLC., a biotech division to focus on the development and advancement of innovative cannabinoid-based nutraceuticals, skincare products and wellness brands.

  • Executed an agreement with CINVESTAV, Mexico, a leading Latin American academic research institution, to advance research targeting endocannabinoid system (ECS) deficiencies.

  • Signed an Exclusive Sales and Distribution Agreement for Mexico and Central America with Inter Cargo and ABA Cargo. Their customer base includes Amazon, Nissan, Unilever, and Walmart, and access to 37 main chain stores, 18 chains of department stores and 49 specialized chains. All together they contribute to 32,192 points of sale in Mexico alone, with additional active relationships in several other Latin American countries.

  • Initiated the Company’s first sales and distribution into the U.S.-based wholesale and retail markets including our first sale to Curaleaf.


2021 and Beyond

  • The Company will more than double last year’s cultivation capacity with 120 acres of photoperiod crop having already been planted and plans to add another 120 acres. At 2,200 plants per acre this represents 528,000 plants.

  • The strategy for use of the 10,000 acres of legacy farming network through Primordia will be to test Tri-crop hemp strains. These strains produce protein, fiber and CBD extract for health-focused products, all in one plant, providing for great cultivation efficiencies and a diversified path forward as we consider what products will be in the highest demand in the future.

  • Design, engineer and build-out plans for TruLife Labs, LLC location are underway. This will complete plans to advance our vertical integration into processing, further securing our own quality assured supply chain and control cost of goods.

  • Continued expansion of the product portfolio as well as sales and distribution within the U.S. wholesale and retail market via e-commerce.

  • Entry into Mexico and Latin America, the largest emerging cannabis market in the world, where the key to capturing market share will be mainly relationships and price point.

  • Continued IP Development and strategic research partnerships to advance TruLife Biotech, LLC.

  • Financing continued growth by acquisition through a $50 million Green Bond offering on the Luxembourg Exchange supported by an ESG Report and a comprehensive Ongoing Business Valuation provided through SingerLewak of Los Angeles, USA.


Conference Details: 

A conference call will be held on July 12, 2021, at 1:15 p.m. (Pacific Standard Time). To participate in the conference call, dial 760-501-8900 and enter PIN 64365 to join.

About Green Hygienics Holdings Inc.

Green Hygienic Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

Hygienics is the science of preserving and promoting the health of individuals, communities, and the planet.

For further information about Green Hygienics Holdings Inc., please visit the Company’s website at:  https://www.greenhygienics.com/

Follow us on Facebook, TwitterInstagram and Linkedin

Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll Free 1.855.802.0299

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements. In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Public Relations:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com


https://www.investorwire.com/newsarticle/?qmstory=8162991935203608
SAN DIEGO, June 23, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") announces today that it has signed an Exclusive Sales and Distribution Agreement for Mexico and Central America with Inter Cargo and ABA Cargo, two sister companies with a successful 50-year sales and distribution track record In Mexico and other Latin American countries.

Under the terms of this agreement, Inter Cargo and ABA Cargo will deploy their sales, marketing, logistics and retail expertise to distribute the Company’s full-suite line of premium CBD products and a hemp cigarette line comprised of retail-ready, multi-SKU brands manufactured in the United States in a Food and Drug Administration (FDA)-approved manufacturing facility.

Inter Cargo and ABA Cargo are connected to 37 main chain stores, 18 chains of department stores and 49 specialized chains. All together they contribute to 32,192 points of sale in Mexico alone, with additional active relationships in several other Latin American countries.

Amazon, Nissan, Unilever, and Walmart, to name a few, are some of the main customers for the two companies. With head offices in Mexico City and branch offices in Laredo, Texas, San Diego, Los Angeles, Aguascalientes and Toluca in Mexico, Inter Cargo and ABA Cargo have built an efficient multi-national distribution and logistics network.

“We are excited to have this agreement in place for strategic, wide-scale distribution of our highly differentiated, safe and superior quality CBD hemp products. Entering into an agreement with our new partners, who have more than 50 years of history in the retail business in Mexico, allows us to tap into a network of leading retailers, presenting Green Hygienics with a first-to-market opportunity to have a retail presence in the largest emerging cannabis market in the world,” stated Kyle MacKinnon, COO of Green Hygienics.  “After proving concept with our ability to cultivate at our property, the largest single USDA Certified Organic hemp for CBD farm in North America, and through recent acquisitions, we have shifted focus to sales and distribution to create revenue for the Company.  This agreement represents a clear path forward to bring value to our shareholders."

About Green Hygienics Holdings Inc.

Green Hygienic Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

Hygienics is the science of preserving and promoting the health of individuals, communities, and the planet.

For further information about Green Hygienics Holdings Inc., please visit the Company’s website at:  https://www.greenhygienics.com/

Follow us on  Facebook, Twitter, Instagram and Linkedin

Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll Free 1.855.802.0299

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements. In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Public Relations:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

https://www.investorwire.com/newsarticle/?qmstory=%207128096134718222

  • Green Hygienics has launched TruLife Biotech LLC. to focus on the development and advancement of innovative cannabinoid-based nutraceutical and skincare products and brands

  • The global industrial hemp market was valued at $5.66 billion in 2020 and is expected to reach a value of $27.72 billion by 2028, growing at a CAGR of 25.17%

  • Hemp-derived cannabinoids have been studied for the last 20 years with nothing more than pre-clinical data but the new collaboration with Cinvestav and the creation of TruLife Biotech can help answer these questions and develop the products necessary for ECS deficiencies


Green Hygienics Holdings (OTCQB: GRYN), a California-based tech-driven enterprise focused on the high standard cultivation of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, recently announced that to advance R&D efforts, it has entered into a scientific research collaboration agreement with Cinvestav, the Center for Research and Advanced Studies of the National Polytechnic Institute of Mexico (Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional) (https://ibn.fm/8UnHo).

Cinvestav is a high-ranked, leading Mexican multidisciplinary scientific research institute that will work with Green Hygienics in R&D efforts to develop cannabinoid-based products targeting the endocannabinoid system (“ECS”) deficiencies in animals and humans. Cinvestav ranks fourth among Latin American research centers and 118th worldwide.

Green Hygienics is also launching TruLife Biotech, LLC. to advance studies in hemp-derived cannabinoid therapies, like the research conducted with Cinvestav. The focus of TruLife Biotech will be the development and advancement of innovative cannabinoid-based nutraceuticals, skincare products, and wellness brands addressing the ECS deficiencies in humans (https://ibn.fm/rCXOQ).

“This research collaboration will be our first project under TruLife Biotech LLC, a Green Hygienics Company focused on the development and advancement of innovative cannabinoid-based nutraceutical and skincare products and brands,” Chief Scientific Officer Dr. Levan Darjania said. “The collaboration with Cinvestav will augment ongoing efforts by both parties to identify and explore selected cannabinoids and terpenes in planned combinations that may act synergistically to protect against pain development and determine their potential efficacy as pain relievers against inflammatory and neuropathic pain.”

It is the collaborative model that Green Hygienics and Cinvestav will develop that will be used to create proprietary and effective products. “Discovery and development of cannabinoid-based products that are truly effective in producing the desired result are global tasks that are based on multidisciplinary approaches, collaborations, and partnerships. After meeting with leading researchers at Cinvestav’s Mexico City Campus, we are confident in our collaboration on the development of new and efficacious products,” COO Kyle MacKinnon added.

Even though the interaction of hemp-derived cannabinoids and the body’s ECS has been studied for the last 20 years, there is only pre-clinical data available. Still, the question that arises is how much of that data is genuine and useful. The company intends to use the new collaboration and TruLife Biotech formation to help answer these questions and develop the products necessary for ECS deficiencies, according to Dr. Darjania.

To further support the initiative, Green Hygienics has published a White Paper through Nutritional Outlook, an MJH Life Sciences(TM) brand that provides intelligent, well-informed insights and industry updates critical to the manufacturers of dietary supplements, health foods, and nutritional beverages.

The White Paper examines the therapeutic potential for cannabinoid health- and wellness-based products, but underlines the need to develop defined, consistent, and targeted products with established standards. The ultimate goal is to develop and promote scientific evidence-based ECS-modulating cannabinoid products that will be trusted by medical communities, physicians, holistic health practitioners, and wellness-oriented end users (https://ibn.fm/9929I).

According to Dr. Darjania, Green Hygienics remains committed to changing the landscape of the industry and continuing the advancement of its hemp-derived cannabinoid phyto-remedy platform, with TruLife serving as a hub of biotechnology innovations and ultimately securing a strategic advantage in the market by introducing novel cannabinoids and biodelivery methods. These steps will help cement Green Hygienics’ role in the global hemp market, which was valued at $5.66 billion worldwide in 2020. The market is expected to grow at a CAGR of 25.17% from 2021 to 2028, resulting in an estimated value of $27.72 billion by 2028 (https://ibn.fm/mZEGs) and multiple expansion opportunities for Green Hygienics and its portfolio.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

About InvestorWire


InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.


With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.


Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.


For more information, please visit https://www.InvestorWire.com


Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer


InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com


InvestorWire is part of the InvestorBrandNetwork.


https://www.investorwire.com/news-articles/green-hygienics-holdings-inc-gryn-joins-forces-with-mexican-scientific-body-creates-new-company-to-research-endocannabinoid-deficiencies/
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Green Hygienics Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is pleased to announce it has entered into a scientific research collaboration agreement with Cinvestav, the Center for Research and Advanced Studies of the National Polytechnic Institute (Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional).

The institute, a high-ranked leading Mexican multidisciplinary scientific research institution, will work with Green Hygienics to advance its R&D efforts through the characterization and development of cannabinoid-based products targeting endocannabinoid system (ECS) deficiencies in animals and humans. Cinvestav ranks fourth among research centers in Latin America and ranks 118th in the world.

Dr. Luisa Lilia Rocha Arrieta, Ph.D. M.D., and Kyle MacKinnon, COO Green Hygienics Holdings Inc.



Dr. Luisa Lilia Rocha Arrieta, Ph.D., M.D., a top research investigator at the Department of Pharmacology at Cinvestav, said, “The treatment of chronic pain has relied heavily on opioids, despite their potential for addiction, overdose and the fact that they often don’t work well when used on a long-term basis. There’s an urgent need for more effective and safer options. These new collaborative research projects, like we’ve established with Green Hygienics, will investigate substances derived from hemp that don’t have psychoactive disadvantages, looking at their basic biological activity and their potential mechanisms of action as endocannabinoid system (ECS) modulators.”

“This research collaboration will be our first project under TruLife Biotech LLC, a Green Hygienics Company focused on the development and advancement of innovative cannabinoid-based nutraceutical and skincare products and brands,” stated Dr. Levan Darjania, chief scientific officer of Green Hygienics. “The collaboration with Cinvestav will augment ongoing efforts by both parties to identify and explore selected cannabinoids and terpenes in planned combinations that may act synergistically to protect against pain development and determine their potential efficacy as pain relievers against inflammatory and neuropathic pain. Therefore, the Company is building its collaborative model with academic institutions and will utilize its TruLife Biotech R&D platform to create proprietary and highly efficacious cannabinoid-based products.”

“Discovery and development of cannabinoid-based products that are truly effective in producing a desired result are global tasks that are based on multidisciplinary approaches, collaborations and partnerships. After meeting with leading researchers at Cinvestav’s Mexico City Campus, we are confident in our collaboration on the development of new and efficacious products,” stated Kyle MacKinnon, COO of Green Hygienics. “Offering researched-backed products that actually work for their intended purpose will lead us to stay ahead of the curve of regulatory approval, allow our products to stand apart from the competition, and is the fastest and most cost-efficient way to expand into new markets,” MacKinnon concluded.

About Cinvestav

The Center for Research and Advanced Studies of the National Polytechnic Institute (Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional) is a Mexican scientific research institution affiliated with the National Polytechnic Institute and founded by President Adolfo López Mateos on April 17, 1961. The institute is divided into 10 research centers; 3 of these are in Mexico City, while the others are dispersed across the country. The institute is divided into 33 departments focused on natural sciences, biological sciences and health, technology and engineering sciences, and social sciences and humanities.

For more information on the Cinvestav Pharmacology department please visit

https://www.cinvestav.mx/Departamentos/Farmacologia.



About Green Hygienics Holdings

Green Hygienic Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

Hygienics is the science of preserving and promoting the health of individuals, communities and the planet.

For further information about Green Hygienics Holdings Inc., please visit the Company’s website at: www.greenhygienics.com

Follow us on:

Facebook, Twitter and Linkedin

Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll Free 1.855.802.0299

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTSThis document contains forward-looking statements.  In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Public Relations:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

https://www.investorwire.com/press-releases/green-hygienics-holdings-inc-gryn-executes-agreement-with-cinvestav-the-leading-mexican-academic-research-institution-to-advance-research-targeting-endocannabinoid-system-ecs-deficiencies/

  • Even major players in the CBD market do not offer detailed and verifiable study results to effectively differentiate their products on the basis of meaningful clinical findings, essentially exploiting the “natural” label without any R&D efforts

  • This industry deficiency represents immense opportunities for R&D-driven companies such as Green Hygienics

  • Green Hygienics intends to use its intellectual and capital resources to establish and apply state-of-the-art research and development to a new generation of cannabinoid-based products having specifically assessed health-wellness efficacies


CBD Reality Check 

Interest in the therapeutic use of hemp-derived nonintoxicating cannabinoids, such as cannabidiol (“CBD”) and cannabigerol (“CBG”), has reached a fever-pitch in recent years followed by the early-stage preclinical discoveries surrounding the tentative functional role of the endocannabinoid system (“ECS”). CBD received a further popular validation since U.S. FDA approved Epidiolex(R) as adjunctive therapy for pediatric patients with drug-resistant epilepsy.

During the last 5-8 years, CBD has been highly acclaimed and heavily hyped. Its medicinal qualities are perceived as limitless by some, and its non-psychoactive nature makes it “suitable” for just about anyone, as it has been claimed by many activists and business entities. The broad-ranging claims of CBD therapeutic utilities are endless, while monopolistic entrepreneurs are rushing the industry in droves, touting first-to-market achievements over quality, research-backed product offerings.

Current Status-Quo and Future Expectations 

A case can be made that the majority of CBD companies simply ignore the lack of efficacy in their products to avoid potentially undermining their commercial utility, preferring to exploit the “natural” label without any R&D efforts, the very efforts that could establish important evidence-based credibility for their products. Companies marketing products containing CBD have been over-exuberant in their claims about its effectiveness. They have been guilty of illegal, sleight-of-hand, exploiting public enthusiasm over cannabis/hemp by portraying all cannabinoids as not only safe but capable of ameliorating the symptoms of many serious medical conditions.

Consequently, the reputation of CBD as a universal “cure-all” puts this still promising substance in the same class as other “natural” panaceas, where anecdotal cases and overwhelmingly biased testimonials supersede the proper efficacy evaluation of already marketed CBD finished products.

Notwithstanding, while CBD and other hemp-derived cannabinoids remain a formally unproven therapeutic option with a known mechanism of action, physicians and holistic health/wellness practitioners remain open to the possible future role of these products in the field of alternative management and prophylaxis of different health conditions such as chronic inflammation and pain. Emerging companies like Green Hygienics Holdings (OTCQB: GRYN) have an opportunity to paint a brighter future for the CBD industry and provide a research-based platform for which these physicians and holistic health/wellness practitioners can specifically select and recommend beneficial products meaningful to their intended purpose of providing patient relief.

To recommend a particular cannabinoid-based product to patients and wellness-oriented end-users, those practitioners need to adequately analyze specific information and study reports on the experimentally assessed systemic exposure, bioavailability and targeted efficacy of a particular product, instead of focusing solely on the certificate of analysis (“COA”) that verifies only the concentration of bio-active ingredients and absence of harmful contaminants.

A very brief survey gathered from the published scientific and commercial papers or conference presentations indicates that even the major players in the CBD market do not possess such study results and reports to differentiate and promote their products based on at least preclinical and/or exploratory clinical study findings.

Green Hygienics is Poised to Address the Current State of the Industry

On the other hand, this particular status-quo represents the immense opportunities for R&D-driven companies like Green Hygienics in an everchanging cannabinoid market landscape. Physicians and holistic health/wellness practitioners are looking for more advanced, evidence-based cannabinoid products with high, unparalleled, and most importantly unbiased therapeutic efficacies of achievable health-beneficial effects. Green Hygienics is an enterprise that has developed a model resting on this exact premise of bringing evidence-based cannabinoid products to market, backed with unbiased therapeutic efficacies, through research-based evidence.

The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state-of-the-art technologies, the company intends to open up a whole new world of fully characterized novel cannabinoids and targeted bio-delivery technologies never before explored.

Green Hygienics is aimed at maximizing the use of intellectual and capital resources. Therefore, the Company has decided to move forward with the establishment of a state-of-art biotechnology R&D facility to focus its resources on the rational and innovative design of formulations, development and experimental evaluation of the new generation cannabinoid-based products with superior bioavailability and specifically assessed health-wellness efficacies.

Discovery and development of highly efficacious cannabinoid-based products is a global task that is based on multidisciplinary approaches, collaborations, and partnerships. Therefore, Green Hygienics is building its collaborative platform with several academic institutions, both domestically and abroad, to utilize well-established endocannabinoid system (“ECS”) target screening models and develop customized wellness products addressing ECS deficiencies. The ultimate goal is to develop and promote highly functional, experimentally assessed and supported efficacious nutraceutical products that will be trusted by medical communities, physicians, holistic health practitioners, and wellness-oriented end users.

For a more in-depth exploration on this topic, please refer to this paper published in Nutritional Outlook by Levan Darjania, PhD. (https://cnw.fm/svoTE).

About Green Hygienics Holdings

Green Hygienics Holdings Inc. (OTCQB: GRYN) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids.

The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

The company intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state-of-the-art technologies, Green Hygienics intends to open a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.

GRYN is building a team of visionary agrotechnology, pharmaceutical and life scientists working at the intersection of nutraceutical, cosmeceutical and pharmaceutical technologies with a goal to improve lives.

View GRYN’s corporate video and follow the company on Facebook, Twitter and Linkedin.

Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll-Free 1.855.802.0299

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN 

About HempWire

HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.HempWire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.HempWire.com/Disclaimer

Do you have questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.HempWire.com
303.498.7722 Office
Editor@HempWire.net

HempWire is part of the InvestorBrandNetwork.

https://www.hempwire.com/current-deficiencies-in-the-rational-development-of-cbd-based-wellness-products/



SAN DIEGO, May 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company"), announces today that it will move forward with the establishment of TruLife Biotech, LLC., to focus on the development and advancement of innovative cannabinoid-based nutraceuticals, skincare products and wellness brands addressing endocannabinoid system (ECS) deficiencies in humans.

“The interaction of hemp-derived cannabinoids with ECS has been rigorously studied for the last 20 years. There’s an awful lot of preclinical data available, and the question is how much is genuine, and practically useful, as far as efficacious, new nutraceutical and wellness product development is concerned. In order to recommend a particular cannabinoid-based product to wellness-oriented end users and practitioners, product developers need to follow the rational product design and development path and support their products and brands with specific information such as safety, stability, experimentally assessed bioavailability and targeted efficacy of a given product,” stated Dr. Levan Darjania, Chief Scientific Officer of Green Hygienics and co-founder of TruLife Biotech.

In support of this initiative, the Company published a White Paper through Nutritional Outlook, an MJH Life Sciences brand that provides astute, well-informed insights and industry updates critical to manufacturers of dietary supplements, health foods and nutritious beverages.

Link to the publication: https://www.nutritionaloutlook.com/view/cbd-is-a-substance-with-poor-systemic-blood-exposure-one-scientist-explains-the-challenge-and-what-it-means

“Green Hygienics is poised to change the landscape of the industry and will continue the advancement of its hemp-derived cannabinoid phyto-remedy platform through TruLife Biotech, LLC.,” Dr. Darjania continued. “The company will serve as a biotechnology innovations hub for the GRYN portfolio companies, and ultimately the Company will secure a strategic advantage in the marketplace by introducing novel cannabinoids and targeted bio-delivery technologies to the formulations within its own brand portfolio.”

Dr. Darjania is a seasoned pharma-professional with over 20 years of experience in biotechnology and pharmaceutical drug research and development. He also held executive positions and led R&D projects at various cannabinoid-based enterprises.

About Green Hygienics Holdings Inc.
Green Hygienic Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The Company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.
Hygienics is the science of preserving and promoting the health of individuals, communities and the planet.

For further information about Green Hygienics Holdings Inc., please visit the Company’s website at: www.greenhygienics.com

Follow us on:

Facebook , Twitter and Linkedin


View our corporate video here .


Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll Free 1.855.802.0299

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Public Relations:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com


Primary Logo



News Provided by GlobeNewswire via QuoteMedia

https://www.investorwire.com/newsarticle/?qmstory=8882354536923915
SAN DIEGO, April 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") announces today the successful completion of its acquisition of two CBD cigarette brands: American Hemp and Diablo. The acquisition includes all related business development assets, such as sales and distribution relationships, trademarks, and digital assets.

The Company has already made two acquisitions so far this year, which included the assets of Primordia to expand its cultivation division (http://bit.ly/grynPrimordia), and Castillo Seeds to fast-track the launch of its genetics division (http://bit.ly/grynCastilloSeed). The acquisition of American Hemp and Diablo launches the Company’s smokables division, which will provide tobacco and nicotine-free alternatives to traditional cigarettes in efforts to help consumers reduce the adverse health effects and premature deaths associated with tobacco use. According to the CDC, the single largest cause of preventable disease and death is smoking, with nearly half a million Americans dying prematurely from tobacco use each year. Additionally, another 16 million Americans suffer from at least one serious disease caused by smoking (https://bit.ly/3uYRTqo).

“The two CBD cigarette brands, American Hemp and Diablo (http://bit.ly/grynhemp1), are extremely well packaged, and the acquisition includes $21.5M worth of inventory at MSRP that we are purchasing at a considerable discount to market,” said Green Hygienics COO Kyle MacKinnon.We plan to use this acquisition to launch the Company’s smokables division and add our Sol Valley Ranch Natural and Sol Valley Ranch Blond premium CBD cigarette brands to the portfolio.

“Again, finished products present an opportunity to create far more revenue for the Company,” MacKinnon said. “British American Tobacco (BAT) recently acquired a 19.9% stake in Organigram. We believe big tobacco companies have a keen interest in the hemp cigarette industry. Our farm is 824 acres, has clean soil reports and USDA Organic Certification, and therefore is one of few that can provide a reliable supply chain solution to facilitate its potential entry into the market.”

About Green Hygienics Holdings
Green Hygienic Holdings Inc. (OTCQB: GRYN) (“Green Hygienics” or the “Company”) is a California-based innovative, technology-driven enterprise focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids.

The Company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe, premium-quality products to consumers as well as to partner with CPG (consumer packaged goods) and pharmaceutical companies.

The Company intends to be a leader in compliances and capabilities in the hemp and cannabinoid supply marketplace. Using state-of-the-art technologies, Green Hygienics intends to open a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.

Hygienics is the science of preserving and promoting the health of individuals, communities and the planet.

For further information about Green Hygienics Holdings Inc., please visit the Company’s website at www.greenhygienics.com.

Follow us on: Facebook, Twitter and Linkedin

View our corporate video: here.

Corporate Communications:
Heidi Thomasen
IR@GreenHygienics.com
Toll Free 1.855.802.0299

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement.

Public Relations:
InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com

Link to the press release: https://www.investorwire.com/press-releases/green-hygienics-holdings-inc-gryn-closes-on-acquisition-of-two-cbd-cigarette-brands/

  • While more research is needed, a recent study provides some evidence that using CBD to transition from tobacco addiction holds significant promise

  • Supply chain issues are the main barrier to entry to the CBD cigarette industry for big tobacco

  • GRYN already owns the largest single industrial hemp for CBD farm in North America


Big tobacco companies are already making strategic moves into the fast-growing hemp industry, as they are exploring hemp-based alternatives to tobacco. To make this move, they require a very large supply of quality industrial hemp from which they can derive the targeted CBD products, more specifically quality hemp biomass and flower to make CBD cigarettes.

There is an emerging trend to replace smoking tobacco with smoking hemp flower. The goal is to ease the conversion from tobacco, with its addictive and negative health effects, to CBD cigarettes as a transition cigarette. While there is yet limited research providing enough evidence that CBD can sufficiently ease tobacco addiction, the results of one recent study provide anecdotal evidence that CBD may positively affect addiction. The study included 700 participants who were asked to inhale/consume CBD when they felt the urge to smoke. 42% of the participants were able to abstain from smoking cigarettes after one month of consuming CBD. This particular study was not conducted in a controlled environment and relied solely on the data provided by the participants (https://cnw.fm/dk3Mq).

Another concern for big tobacco companies interested in the hemp space is the quality of soil, as soil contamination, caused by poor farming practices in the past, is considered an issue, primarily in Europe and the Eastern parts of the United States.

Green Hygienics Holdings (OTCQB: GRYN) addresses this problem as well. The soils on its’ 824-acre Sol Valley Ranch are pristine, which is a critical factor in supply chain requirements.

With the capability of ensuring a steady supply of quality hemp, GRYN is one of the few companies that has the ability to supply big tobacco and is set to leverage multiple growth opportunities resulting from a growing demand for hemp in North America following the entry of big tobacco companies into the market.

Additionally, Green Hygienics’ U.S. Food and Drug Administration registration as of August 26, 2020, also opens up more expansive growth opportunities for the company, allowing it to supply hemp to various industries, including tobacco.

Green Hygienics is uniquely positioned to meet the growing demand for hemp resulting from big tobacco entering the market. There are only a handful of companies in the entire industry that have the capacity to meet this kind of demand.

CEO Ron Loudoun discussed the company’s growth plans in more detail when he was featured on the Bell2Bell podcast at the end of March (https://cnw.fm/77EGl).

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://cnw.fm/GRYN

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

https://www.cannabisnewswire.com/green-hygienics-holdings-inc-gryn-expanding-potential-for-big-tobacco-to-enter-cbd-cigarette-market/

  • “Cannabis manufacturers that ignore the obvious progression toward an FDA-like industry will not survive the long game,” writes industry expert

  • GRYN farm and facilities have already gained USDA Organic certification, FDA registration

  • Green Hygienics ideally positioned to innovate, drive new commercial products entirely compliant to USDA and FDA regulatory requirements


As government entities more closely analyze cannabis and the federal regulations that surround the industry, savvy companies such as Green Hygienics (OTCQB: GRYN) are already working to position themselves to offer safe, high-quality products and services. Anticipating what future regulations might look like — and working to meet those guidelines right now — is a hallmark of GRYN.

“Cannabis manufacturers that ignore the obvious progression toward an FDA-like industry will not survive the long game,” writes Kathleen May, a regulatory professional with more than two decades of experience in the Good Manufacturing Practice space, in a recent “Cannabis Industry Journal” article (https://ibn.fm/NiJCp). “Those that embrace the momentum and properly plan to mitigate product and business risk — those who demonstrate integrity and are truly in this space to ensure safe, effective and quality products to consumers will come out on top, gain credibility and secure brand recognition.”

Strategic planning and a long-running commitment to quality are hallmarks of Green Hygienics. The company has a track record of working to obtain significant government approvals and certifications. In April 2020, Green Hygienics received USDA Organic Certification for its 824-acre farm, which includes 400,000 square feet of greenhouse space (https://ibn.fm/ac2Cw).

The USDA Organic seal is one of the most recognized certifications among U.S. consumers and provides assurance to consumers who may be concerned about the safety of CBD products. In addition to assuring that no synthetic fertilizers, pesticides or herbicides have been used in the cultivation of hemp, the USDA organic certification ensures that farmers are using tillage and cultivation practices that maintain or improve the condition of soil and minimize soil erosion through crop rotations, cover crops and the application of plant and animal materials.

“GRYN owns the largest single, USDA Organic-Certified Industrial Hemp for CBD farms in North America,” said GRYN CEO Ron Loudoun. “Having the capacity to provide a secure supply chain of considerable size is a very significant and a clear strategic advantage. . . . This is a great milestone to have achieved. The demand for organic product is growing rapidly with increasing consumer concerns around product efficacy. USDA Organic Certification is the foundation in our objective to supply the underserved medical and pharmaceutical industry.”

In October 2020, Green Hygienics announced that it was registered with the U.S. Food and Drug Administration pursuant to the Federal Food Drug and Cosmetic Act, as amended by the Bioterrorism Act of 2002 (https://ibn.fm/pQEHH).

“The achievement of FDA registration strengthens our company’s core mission to provide product efficacy to the pharmaceutical industry and consumers alike,” said GRYN chief scientific officer Dr. Levan Darjania. “The company is well positioned to instill consumer confidence and change the landscape of the industry by bringing safe and consistent products to market. With our previously announced USDA Organic Certification and FDA Facility Registration, we are well positioned to continue to innovate through the research our teams are involved in and drive new commercial products entirely compliant to USDA and FDA regulatory requirements.”

Clearly Green Hygienics is positioned to come out on top. The California-based, innovative, technology-driven enterprise is focused on the high standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company aims to be a leader in compliance and capabilities in the hemp and cannabinoid supply marketplace. By leveraging state-of-the-art technologies, GRYN intends to open up a whole new world of novel cannabinoids and targeted bio-delivery technologies never before explored, thus solving the issues of stability, pharmacokinetics, biological tissue penetration and bioavailability.

For more information, visit the company’s website at www.GreenHygienics.com.

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at http://ibn.fm/GRYN

About InvestorWire


InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.


With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.


Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.


For more information, please visit https://www.InvestorWire.com


Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer


InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com


InvestorWire is part of the InvestorBrandNetwork


https://www.investorwire.com/news-articles/green-hygienics-holdings-inc-gryn-embracing-momentum-set-to-come-out-on-top/